Robert L Copeland1,2, Desta Beyene2, Victor Apprey3, Mohammad R Daremipouran2, Tammey J Naab4, Olakunle O Kassim5, Yasmine M Kanaan6,5. 1. Department of Pharmacology, Howard University, Washington, DC, U.S.A. 2. Cancer Center, Howard University, Washington, DC, U.S.A. 3. Department of Community and Family Medicine, Howard University, Washington, DC, U.S.A. 4. Department of Pathology, Howard University, Washington, DC, U.S.A. 5. Department of Microbiology, Howard University, Washington, DC, U.S.A. 6. Cancer Center, Howard University, Washington, DC, U.S.A. ymkanaan@howard.edu.
Abstract
BACKGROUND/AIM: Denaturing high-performance liquid chromatography (DHPLC) is a technique that is used to detect mutations. The aim of the present study was to determine whether DHPLC elution patterns of vitamin D receptor (VDR) gene PCR products can serve as indicators of susceptibility to prostate cancer (PCa) risk. MATERIALS AND METHODS: DNA samples of PCa cases and controls were screened for mutations and/or polymorphisms in coding exons of VDR gene using DHPLC analysis. Logistic regression, phi-coefficient (ϕ), and Backward Wald models were used to analyze the data. RESULTS: Similar elution patterns of exons 1, 6, 7 and 9 along with higher prevalence of heteroduplex DNA were observed in PCa samples than in controls. Exons 4 and 8 had highly significant protective effects (p<0.05). Whereas, exons 5, 7, and 9 were perfectly positively correlated with PCa risk (ϕ=1), thus presenting candidate exons significantly associated with susceptibility to PCa. CONCLUSION: DHPLC elution patterns of the selected exons could be useful to predict susceptibility to develop PCa. Copyright
BACKGROUND/AIM: Denaturing high-performance liquid chromatography (DHPLC) is a technique that is used to detect mutations. The aim of the present study was to determine whether DHPLC elution patterns of vitamin D receptor (VDR) gene PCR products can serve as indicators of susceptibility to prostate cancer (PCa) risk. MATERIALS AND METHODS: DNA samples of PCa cases and controls were screened for mutations and/or polymorphisms in coding exons of VDR gene using DHPLC analysis. Logistic regression, phi-coefficient (ϕ), and Backward Wald models were used to analyze the data. RESULTS: Similar elution patterns of exons 1, 6, 7 and 9 along with higher prevalence of heteroduplex DNA were observed in PCa samples than in controls. Exons 4 and 8 had highly significant protective effects (p<0.05). Whereas, exons 5, 7, and 9 were perfectly positively correlated with PCa risk (ϕ=1), thus presenting candidate exons significantly associated with susceptibility to PCa. CONCLUSION:DHPLC elution patterns of the selected exons could be useful to predict susceptibility to develop PCa. Copyright
Authors: P Berthon; A Valeri; A Cohen-Akenine; E Drelon; T Paiss; G Wöhr; A Latil; P Millasseau; I Mellah; N Cohen; H Blanché; C Bellané-Chantelot; F Demenais; P Teillac; A Le Duc; R de Petriconi; R Hautmann; I Chumakov; L Bachner; N J Maitland; R Lidereau; W Vogel; G Fournier; P Mangin; O Cussenot Journal: Am J Hum Genet Date: 1998-06 Impact factor: 11.025
Authors: Emmanuel Y Jingwi; Muneer Abbas; Luisel Ricks-Santi; Danyelle Winchester; Desta Beyene; Agnes Day; Tammey J Naab; Olakunle O Kassim; Georgia M Dunston; Robert L Copeland; Yasmine M Kanaan Journal: Anticancer Res Date: 2015-03 Impact factor: 2.480
Authors: L Correa-Cerro; P Berthon; J Häussler; S Bochum; E Drelon; P Mangin; G Fournier; T Paiss; O Cussenot; W Vogel Journal: Hum Genet Date: 1999-09 Impact factor: 4.132
Authors: Vanessa M Hayes; Gianluca Severi; Emma J D Padilla; Sarah A Eggleton; Melissa C Southey; Robert L Sutherland; John L Hopper; Graham G Giles Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-04 Impact factor: 4.254
Authors: N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman Journal: Nature Date: 1994-01-20 Impact factor: 49.962
Authors: Ingrid Oakley-Girvan; David Feldman; T Ross Eccleshall; Richard P Gallagher; Anna H Wu; Laurence N Kolonel; Jerry Halpern; Raymond R Balise; Dee W West; Ralph S Paffenbarger; Alice S Whittemore Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-08 Impact factor: 4.254
Authors: Desta A Beyene; Mohammad R Daremipouran; Victor Apprey; Tammey Naab; Olakunle O Kassim; Robert L Copeland; Yasmine M Kanaan Journal: Cancer Genomics Proteomics Date: 2020 Nov-Dec Impact factor: 4.069